Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-08-04

AUTHORS

K K McLaurin, A M Farr, S W Wade, D R Diakun, D L Stewart

ABSTRACT

Objective:Infection with respiratory syncytial virus (RSV), which causes lower respiratory tract infections, is the leading cause of hospitalization among children <1 year old in the United States. Risk factors for RSV hospitalization include premature birth and younger chronologic age, along with several comorbid conditions. However, in terms of RSV hospitalization costs, premature infants are rarely studied separately from full-term infants. The objective of this study is to describe the cost and severity of RSV hospitalizations among preterm and full-term infants without chronic lung disease or other high-risk conditions.Study Design:This analysis used Truven Health Market Scan Multi-State Medicaid and Commercial Claims and Encounters databases, which contain a combined 4 million births from 2003 to 2013. Infants with comorbid conditions associated with increased risk for RSV infection were excluded. Infants were classified as preterm (<29, 29−30, 31−32, 33−34 and 35−36 weeks’ gestational age (wGA)) or full term based on diagnostic coding. Health-care claims during the first year of life were evaluated for RSV hospitalizations, defined as inpatient claims with a diagnosis code for RSV in any position. Costs of RSV hospitalizations were captured and reported in 2014 USD. Inpatient claims for RSV hospitalizations were evaluated for the presence of codes indicating admission to the intensive care unit (ICU), use of mechanical ventilation (MV) and length of stay. These three measures were used to describe hospital severity. Chronologic age at the time of RSV hospitalization was also captured. Data were summarized and no statistical comparisons were conducted.Results:There were 1 683 188 infants insured through Medicaid and 1 663 832 infants insured through commercial plans born from 1 July 2003 to 30 June 2013. Of those, 10.8 and 8.8% in each database, respectively, were born prematurely. There were 29 967 Medicaid-insured infants and 16 310 commercially insured infants with an RSV hospitalization during their first year of life. Mean first-year RSV hospitalization costs were higher for preterm infants, ranging from $8324 and $10 570 for full-term infants to $15 839 and $19 931 for preterm infants 33–34 wGA, and to $39 354 and $40 813 for preterm infants <29 wGA, among Medicaid-insured and commercially insured infants, respectively. RSV hospitalizations also tended to be more severe among preterm infants, with longer lengths of stay, a higher proportion of infants admitted to the intensive care unit (ICU) and increased use of MV compared with full-term infants. Mean costs of RSV hospitalizations with a PICU admission ranged from approximately $35 000 to $89 000. In both Medicaid and commercial groups, costs were greater for infants hospitalized at <90 days of age compared with older infants.Conclusions:Infants who were born prematurely and those hospitalized at <90 days of age have more costly and more severe RSV hospitalizations during the first year of life. These findings demonstrate important differences in the costs and severity of first-year RSV hospitalizations of premature and full-term infants. These differences are likely to be obscured in combined analysis, in which full-term infants predominate. Clinical guidelines and health-care policies relating to RSV would benefit from the availability of data obtained from separate analyses of these two infant subgroups. More... »

PAGES

990-996

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/jp.2016.113

DOI

http://dx.doi.org/10.1038/jp.2016.113

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007747632

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27490190


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1114", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Paediatrics and Reproductive Medicine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Databases, Factual", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gestational Age", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hospitalization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant, Newborn", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant, Premature", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insurance, Health", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intensive Care Units, Neonatal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Length of Stay", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medicaid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Respiratory Syncytial Virus Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Health Economics and Outcomes Research, Medical Affairs, AstraZeneca, Gaithersburg, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.418152.b", 
          "name": [
            "Health Economics and Outcomes Research, Medical Affairs, AstraZeneca, Gaithersburg, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McLaurin", 
        "givenName": "K K", 
        "id": "sg:person.01116472424.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116472424.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Life Sciences, Truven Health Analytics an IBM Company, Cambridge, MA, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Life Sciences, Truven Health Analytics an IBM Company, Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Farr", 
        "givenName": "A M", 
        "id": "sg:person.014011544305.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014011544305.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wade Outcomes Research and Consulting, Salt Lake City, UT, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Wade Outcomes Research and Consulting, Salt Lake City, UT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wade", 
        "givenName": "S W", 
        "id": "sg:person.0617012057.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617012057.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Life Sciences, Truven Health Analytics, an IBM Company, Bethesda, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.460065.1", 
          "name": [
            "Life Sciences, Truven Health Analytics, an IBM Company, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Diakun", 
        "givenName": "D R", 
        "id": "sg:person.015404505305.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015404505305.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, University of Louisville School of Medicine, University of Louisville Hospital, Kosair Children\u2019s Hospital, Louisville, KY, USA", 
          "id": "http://www.grid.ac/institutes/grid.413750.4", 
          "name": [
            "Department of Pediatrics, University of Louisville School of Medicine, University of Louisville Hospital, Kosair Children\u2019s Hospital, Louisville, KY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stewart", 
        "givenName": "D L", 
        "type": "Person"
      }
    ], 
    "datePublished": "2016-08-04", 
    "datePublishedReg": "2016-08-04", 
    "description": "Objective:Infection with respiratory syncytial virus (RSV), which causes lower respiratory tract infections, is the leading cause of hospitalization among children <1 year old in the United States. Risk factors for RSV hospitalization include premature birth and younger chronologic age, along with several comorbid conditions. However, in terms of RSV hospitalization costs, premature infants are rarely studied separately from full-term infants. The objective of this study is to describe the cost and severity of RSV hospitalizations among preterm and full-term infants without chronic lung disease or other high-risk conditions.Study Design:This analysis used Truven Health Market Scan Multi-State Medicaid and Commercial Claims and Encounters databases, which contain a combined 4 million births from 2003 to 2013. Infants with comorbid conditions associated with increased risk for RSV infection were excluded. Infants were classified as preterm (<29, 29\u221230, 31\u221232, 33\u221234 and 35\u221236 weeks\u2019 gestational age (wGA)) or full term based on diagnostic coding. Health-care claims during the first year of life were evaluated for RSV hospitalizations, defined as inpatient claims with a diagnosis code for RSV in any position. Costs of RSV hospitalizations were captured and reported in 2014 USD. Inpatient claims for RSV hospitalizations were evaluated for the presence of codes indicating admission to the intensive care unit (ICU), use of mechanical ventilation (MV) and length of stay. These three measures were used to describe hospital severity. Chronologic age at the time of RSV hospitalization was also captured. Data were summarized and no statistical comparisons were conducted.Results:There were 1\u2009683\u2009188 infants insured through Medicaid and 1\u2009663\u2009832 infants insured through commercial plans born from 1 July 2003 to 30 June 2013. Of those, 10.8 and 8.8% in each database, respectively, were born prematurely. There were 29\u2009967 Medicaid-insured infants and 16\u2009310 commercially insured infants with an RSV hospitalization during their first year of life. Mean first-year RSV hospitalization costs were higher for preterm infants, ranging from $8324 and $10\u2009570 for full-term infants to $15\u2009839 and $19\u2009931 for preterm infants 33\u201334 wGA, and to $39\u2009354 and $40\u2009813 for preterm infants <29 wGA, among Medicaid-insured and commercially insured infants, respectively. RSV hospitalizations also tended to be more severe among preterm infants, with longer lengths of stay, a higher proportion of infants admitted to the intensive care unit (ICU) and increased use of MV compared with full-term infants. Mean costs of RSV hospitalizations with a PICU admission ranged from approximately $35\u2009000 to $89\u2009000. In both Medicaid and commercial groups, costs were greater for infants hospitalized at <90 days of age compared with older infants.Conclusions:Infants who were born prematurely and those hospitalized at <90 days of age have more costly and more severe RSV hospitalizations during the first year of life. These findings demonstrate important differences in the costs and severity of first-year RSV hospitalizations of premature and full-term infants. These differences are likely to be obscured in combined analysis, in which full-term infants predominate. Clinical guidelines and health-care policies relating to RSV would benefit from the availability of data obtained from separate analyses of these two infant subgroups.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/jp.2016.113", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1095220", 
        "issn": [
          "0743-8346", 
          "1476-5543"
        ], 
        "name": "Journal of Perinatology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "36"
      }
    ], 
    "keywords": [
      "full-term infants", 
      "intensive care unit", 
      "respiratory syncytial virus", 
      "RSV hospitalization", 
      "preterm infants", 
      "mechanical ventilation", 
      "days of age", 
      "comorbid conditions", 
      "care unit", 
      "hospitalization costs", 
      "inpatient claims", 
      "chronologic age", 
      "use of MV", 
      "lower respiratory tract infections", 
      "Multi-State Medicaid", 
      "preterm infants 33", 
      "respiratory tract infections", 
      "cause of hospitalization", 
      "chronic lung disease", 
      "length of stay", 
      "first year", 
      "younger chronologic age", 
      "high-risk conditions", 
      "health care claims", 
      "health care policy", 
      "hospital severity", 
      "infants 33", 
      "PICU admission", 
      "tract infections", 
      "RSV infection", 
      "premature infants", 
      "syncytial virus", 
      "premature birth", 
      "infant subgroups", 
      "hospitalization outcomes", 
      "lung disease", 
      "Encounters Database", 
      "diagnosis codes", 
      "risk factors", 
      "clinical guidelines", 
      "Commercial Claims", 
      "hospitalization", 
      "full term", 
      "mean cost", 
      "diagnostic coding", 
      "infants", 
      "older infants", 
      "Medicaid", 
      "infection", 
      "severity", 
      "commercial plans", 
      "preterm", 
      "age", 
      "longer length", 
      "admission", 
      "stay", 
      "higher proportion", 
      "birth", 
      "separate analysis", 
      "years", 
      "days", 
      "statistical comparison", 
      "important differences", 
      "disease", 
      "ventilation", 
      "life", 
      "outcomes", 
      "virus", 
      "United States", 
      "subgroups", 
      "differences", 
      "children", 
      "risk", 
      "database", 
      "presence of code", 
      "cause", 
      "guidelines", 
      "group", 
      "proportion", 
      "findings", 
      "use", 
      "factors", 
      "data", 
      "analysis", 
      "study", 
      "units", 
      "measures", 
      "commercial groups", 
      "length", 
      "presence", 
      "objective", 
      "conditions", 
      "plan", 
      "availability of data", 
      "time", 
      "USD", 
      "comparison", 
      "cost", 
      "availability", 
      "claims", 
      "terms", 
      "state", 
      "position", 
      "policy", 
      "coding", 
      "code"
    ], 
    "name": "Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants", 
    "pagination": "990-996", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007747632"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/jp.2016.113"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27490190"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/jp.2016.113", 
      "https://app.dimensions.ai/details/publication/pub.1007747632"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_684.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/jp.2016.113"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/jp.2016.113'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/jp.2016.113'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/jp.2016.113'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/jp.2016.113'


 

This table displays all metadata directly associated to this object as RDF triples.

278 TRIPLES      21 PREDICATES      150 URIs      142 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/jp.2016.113 schema:about N0c1d29a24be34753929a4b52551f5494
2 N15aa6ee9053041599f913744adf79a72
3 N1dd576c8133a411f97df2e17a66bc776
4 N25e342826cfd4a7d890f9aba4cef3b63
5 N452fb81cd15946fdbef6922ca78cfc73
6 N74a904d137e74216a5a014a5166b9b21
7 N752debd4a4024b56b0ae8deff68ba3ed
8 N7d9d751871bd42078a630e4eaae6adc7
9 N8b185afdfedf40a3aa085e4672fabfd8
10 N991c5955f1e0410fa061a9ff95995294
11 Nc7c34e500d1b4dd4a27814f9d9f98fb8
12 Ncb55451a3af14a25862c921b7a19a089
13 Ncc9b65d2eea24197acd38b90064a888b
14 Ndcff1664fba942d0a9241fdb6b645353
15 Ndf7f2d407a574b5bb16b7123a1c2ad7a
16 Ne6c20ff99adf40578a6c68db2414112c
17 Ned4fe39daca54727ad71cb3c7c19f849
18 Nf8acf43169a644ab9b625a46d5ec38b4
19 anzsrc-for:11
20 anzsrc-for:1114
21 schema:author Nfd109e711cb34e9488c8081d0e5bb4fa
22 schema:datePublished 2016-08-04
23 schema:datePublishedReg 2016-08-04
24 schema:description Objective:Infection with respiratory syncytial virus (RSV), which causes lower respiratory tract infections, is the leading cause of hospitalization among children <1 year old in the United States. Risk factors for RSV hospitalization include premature birth and younger chronologic age, along with several comorbid conditions. However, in terms of RSV hospitalization costs, premature infants are rarely studied separately from full-term infants. The objective of this study is to describe the cost and severity of RSV hospitalizations among preterm and full-term infants without chronic lung disease or other high-risk conditions.Study Design:This analysis used Truven Health Market Scan Multi-State Medicaid and Commercial Claims and Encounters databases, which contain a combined 4 million births from 2003 to 2013. Infants with comorbid conditions associated with increased risk for RSV infection were excluded. Infants were classified as preterm (<29, 29−30, 31−32, 33−34 and 35−36 weeks’ gestational age (wGA)) or full term based on diagnostic coding. Health-care claims during the first year of life were evaluated for RSV hospitalizations, defined as inpatient claims with a diagnosis code for RSV in any position. Costs of RSV hospitalizations were captured and reported in 2014 USD. Inpatient claims for RSV hospitalizations were evaluated for the presence of codes indicating admission to the intensive care unit (ICU), use of mechanical ventilation (MV) and length of stay. These three measures were used to describe hospital severity. Chronologic age at the time of RSV hospitalization was also captured. Data were summarized and no statistical comparisons were conducted.Results:There were 1 683 188 infants insured through Medicaid and 1 663 832 infants insured through commercial plans born from 1 July 2003 to 30 June 2013. Of those, 10.8 and 8.8% in each database, respectively, were born prematurely. There were 29 967 Medicaid-insured infants and 16 310 commercially insured infants with an RSV hospitalization during their first year of life. Mean first-year RSV hospitalization costs were higher for preterm infants, ranging from $8324 and $10 570 for full-term infants to $15 839 and $19 931 for preterm infants 33–34 wGA, and to $39 354 and $40 813 for preterm infants <29 wGA, among Medicaid-insured and commercially insured infants, respectively. RSV hospitalizations also tended to be more severe among preterm infants, with longer lengths of stay, a higher proportion of infants admitted to the intensive care unit (ICU) and increased use of MV compared with full-term infants. Mean costs of RSV hospitalizations with a PICU admission ranged from approximately $35 000 to $89 000. In both Medicaid and commercial groups, costs were greater for infants hospitalized at <90 days of age compared with older infants.Conclusions:Infants who were born prematurely and those hospitalized at <90 days of age have more costly and more severe RSV hospitalizations during the first year of life. These findings demonstrate important differences in the costs and severity of first-year RSV hospitalizations of premature and full-term infants. These differences are likely to be obscured in combined analysis, in which full-term infants predominate. Clinical guidelines and health-care policies relating to RSV would benefit from the availability of data obtained from separate analyses of these two infant subgroups.
25 schema:genre article
26 schema:inLanguage en
27 schema:isAccessibleForFree true
28 schema:isPartOf N0f69ec971ee749f5955a8ef3ab708a9b
29 N63c6292195ba45e1b5c2f78ffb9cd54a
30 sg:journal.1095220
31 schema:keywords Commercial Claims
32 Encounters Database
33 Medicaid
34 Multi-State Medicaid
35 PICU admission
36 RSV hospitalization
37 RSV infection
38 USD
39 United States
40 admission
41 age
42 analysis
43 availability
44 availability of data
45 birth
46 care unit
47 cause
48 cause of hospitalization
49 children
50 chronic lung disease
51 chronologic age
52 claims
53 clinical guidelines
54 code
55 coding
56 commercial groups
57 commercial plans
58 comorbid conditions
59 comparison
60 conditions
61 cost
62 data
63 database
64 days
65 days of age
66 diagnosis codes
67 diagnostic coding
68 differences
69 disease
70 factors
71 findings
72 first year
73 full term
74 full-term infants
75 group
76 guidelines
77 health care claims
78 health care policy
79 high-risk conditions
80 higher proportion
81 hospital severity
82 hospitalization
83 hospitalization costs
84 hospitalization outcomes
85 important differences
86 infant subgroups
87 infants
88 infants 33
89 infection
90 inpatient claims
91 intensive care unit
92 length
93 length of stay
94 life
95 longer length
96 lower respiratory tract infections
97 lung disease
98 mean cost
99 measures
100 mechanical ventilation
101 objective
102 older infants
103 outcomes
104 plan
105 policy
106 position
107 premature birth
108 premature infants
109 presence
110 presence of code
111 preterm
112 preterm infants
113 preterm infants 33
114 proportion
115 respiratory syncytial virus
116 respiratory tract infections
117 risk
118 risk factors
119 separate analysis
120 severity
121 state
122 statistical comparison
123 stay
124 study
125 subgroups
126 syncytial virus
127 terms
128 time
129 tract infections
130 units
131 use
132 use of MV
133 ventilation
134 virus
135 years
136 younger chronologic age
137 schema:name Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants
138 schema:pagination 990-996
139 schema:productId N69c176e911784fb182ece56a9ffdef9b
140 N9e9f8d3bf329436585e4212ae803ff35
141 Naf7d44cf3a5d4e49985e03a8e96966da
142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007747632
143 https://doi.org/10.1038/jp.2016.113
144 schema:sdDatePublished 2022-05-20T07:31
145 schema:sdLicense https://scigraph.springernature.com/explorer/license/
146 schema:sdPublisher N97863311262940a1abbc8ae36f9cfb4f
147 schema:url https://doi.org/10.1038/jp.2016.113
148 sgo:license sg:explorer/license/
149 sgo:sdDataset articles
150 rdf:type schema:ScholarlyArticle
151 N0c1d29a24be34753929a4b52551f5494 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Male
153 rdf:type schema:DefinedTerm
154 N0f69ec971ee749f5955a8ef3ab708a9b schema:issueNumber 11
155 rdf:type schema:PublicationIssue
156 N0ff3f69b4f044dae9dbf8a5f2f7ac931 rdf:first Nc776098ca15f4a6583eeb93e784d556e
157 rdf:rest rdf:nil
158 N15aa6ee9053041599f913744adf79a72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Medicaid
160 rdf:type schema:DefinedTerm
161 N1dd576c8133a411f97df2e17a66bc776 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name United States
163 rdf:type schema:DefinedTerm
164 N25e342826cfd4a7d890f9aba4cef3b63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Length of Stay
166 rdf:type schema:DefinedTerm
167 N452fb81cd15946fdbef6922ca78cfc73 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Insurance, Health
169 rdf:type schema:DefinedTerm
170 N63c6292195ba45e1b5c2f78ffb9cd54a schema:volumeNumber 36
171 rdf:type schema:PublicationVolume
172 N69c176e911784fb182ece56a9ffdef9b schema:name doi
173 schema:value 10.1038/jp.2016.113
174 rdf:type schema:PropertyValue
175 N74a904d137e74216a5a014a5166b9b21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Gestational Age
177 rdf:type schema:DefinedTerm
178 N752debd4a4024b56b0ae8deff68ba3ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Intensive Care Units, Neonatal
180 rdf:type schema:DefinedTerm
181 N79b679acdcf546e69e5c0561b68ae77e rdf:first sg:person.014011544305.49
182 rdf:rest Nebcf8191669a46328abeafb3af853e26
183 N7d9d751871bd42078a630e4eaae6adc7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Databases, Factual
185 rdf:type schema:DefinedTerm
186 N8b185afdfedf40a3aa085e4672fabfd8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Humans
188 rdf:type schema:DefinedTerm
189 N97863311262940a1abbc8ae36f9cfb4f schema:name Springer Nature - SN SciGraph project
190 rdf:type schema:Organization
191 N991c5955f1e0410fa061a9ff95995294 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Respiratory Syncytial Virus Infections
193 rdf:type schema:DefinedTerm
194 N9e9f8d3bf329436585e4212ae803ff35 schema:name pubmed_id
195 schema:value 27490190
196 rdf:type schema:PropertyValue
197 Naf7d44cf3a5d4e49985e03a8e96966da schema:name dimensions_id
198 schema:value pub.1007747632
199 rdf:type schema:PropertyValue
200 Nc776098ca15f4a6583eeb93e784d556e schema:affiliation grid-institutes:grid.413750.4
201 schema:familyName Stewart
202 schema:givenName D L
203 rdf:type schema:Person
204 Nc7c34e500d1b4dd4a27814f9d9f98fb8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Infant, Newborn
206 rdf:type schema:DefinedTerm
207 Ncb55451a3af14a25862c921b7a19a089 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Infant, Premature
209 rdf:type schema:DefinedTerm
210 Ncc9b65d2eea24197acd38b90064a888b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Severity of Illness Index
212 rdf:type schema:DefinedTerm
213 Ndcff1664fba942d0a9241fdb6b645353 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Female
215 rdf:type schema:DefinedTerm
216 Ndf7f2d407a574b5bb16b7123a1c2ad7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Risk Factors
218 rdf:type schema:DefinedTerm
219 Ne60c48ff2c5f48dd8279d0db0bfc9aed rdf:first sg:person.015404505305.76
220 rdf:rest N0ff3f69b4f044dae9dbf8a5f2f7ac931
221 Ne6c20ff99adf40578a6c68db2414112c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
222 schema:name Infant
223 rdf:type schema:DefinedTerm
224 Nebcf8191669a46328abeafb3af853e26 rdf:first sg:person.0617012057.00
225 rdf:rest Ne60c48ff2c5f48dd8279d0db0bfc9aed
226 Ned4fe39daca54727ad71cb3c7c19f849 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
227 schema:name Age Factors
228 rdf:type schema:DefinedTerm
229 Nf8acf43169a644ab9b625a46d5ec38b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
230 schema:name Hospitalization
231 rdf:type schema:DefinedTerm
232 Nfd109e711cb34e9488c8081d0e5bb4fa rdf:first sg:person.01116472424.97
233 rdf:rest N79b679acdcf546e69e5c0561b68ae77e
234 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
235 schema:name Medical and Health Sciences
236 rdf:type schema:DefinedTerm
237 anzsrc-for:1114 schema:inDefinedTermSet anzsrc-for:
238 schema:name Paediatrics and Reproductive Medicine
239 rdf:type schema:DefinedTerm
240 sg:journal.1095220 schema:issn 0743-8346
241 1476-5543
242 schema:name Journal of Perinatology
243 schema:publisher Springer Nature
244 rdf:type schema:Periodical
245 sg:person.01116472424.97 schema:affiliation grid-institutes:grid.418152.b
246 schema:familyName McLaurin
247 schema:givenName K K
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116472424.97
249 rdf:type schema:Person
250 sg:person.014011544305.49 schema:affiliation grid-institutes:None
251 schema:familyName Farr
252 schema:givenName A M
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014011544305.49
254 rdf:type schema:Person
255 sg:person.015404505305.76 schema:affiliation grid-institutes:grid.460065.1
256 schema:familyName Diakun
257 schema:givenName D R
258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015404505305.76
259 rdf:type schema:Person
260 sg:person.0617012057.00 schema:affiliation grid-institutes:None
261 schema:familyName Wade
262 schema:givenName S W
263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617012057.00
264 rdf:type schema:Person
265 grid-institutes:None schema:alternateName Life Sciences, Truven Health Analytics an IBM Company, Cambridge, MA, USA
266 Wade Outcomes Research and Consulting, Salt Lake City, UT, USA
267 schema:name Life Sciences, Truven Health Analytics an IBM Company, Cambridge, MA, USA
268 Wade Outcomes Research and Consulting, Salt Lake City, UT, USA
269 rdf:type schema:Organization
270 grid-institutes:grid.413750.4 schema:alternateName Department of Pediatrics, University of Louisville School of Medicine, University of Louisville Hospital, Kosair Children’s Hospital, Louisville, KY, USA
271 schema:name Department of Pediatrics, University of Louisville School of Medicine, University of Louisville Hospital, Kosair Children’s Hospital, Louisville, KY, USA
272 rdf:type schema:Organization
273 grid-institutes:grid.418152.b schema:alternateName Health Economics and Outcomes Research, Medical Affairs, AstraZeneca, Gaithersburg, MD, USA
274 schema:name Health Economics and Outcomes Research, Medical Affairs, AstraZeneca, Gaithersburg, MD, USA
275 rdf:type schema:Organization
276 grid-institutes:grid.460065.1 schema:alternateName Life Sciences, Truven Health Analytics, an IBM Company, Bethesda, MD, USA
277 schema:name Life Sciences, Truven Health Analytics, an IBM Company, Bethesda, MD, USA
278 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...